Psychiatric or Mood Diseases or Conditions
8
0
0
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
12.5%
1 terminated out of 8 trials
83.3%
-3.2% vs benchmark
13%
1 trials in Phase 3/4
40%
2 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (8)
Effect and Cost-effectiveness of the Everyday Life Rehabilitation Intervention
Effectiveness of Telepsychiatry With Randomized Waitlist Control Utilizing Patient Reported Outcome Measures
Effects of RME on Engagement in Buprenorphine Treatment
The Effects of Animal Assisted Therapy in Outpatient Psychiatry Clinics
Treatment Efficacy of Mindfulness-based Cognitive Therapy for Distress in Advanced Cancer Patients
PRIME Care (PRecision Medicine In MEntal Health Care) 2.0
Does Valproate Increase Levels of Folate Receptor Autoantibodies in Women?
BRIA - Bridging Intervention in Anesthesiology